SG11202009570SA - Atf6 inhibitors and uses thereof - Google Patents
Atf6 inhibitors and uses thereofInfo
- Publication number
- SG11202009570SA SG11202009570SA SG11202009570SA SG11202009570SA SG11202009570SA SG 11202009570S A SG11202009570S A SG 11202009570SA SG 11202009570S A SG11202009570S A SG 11202009570SA SG 11202009570S A SG11202009570S A SG 11202009570SA SG 11202009570S A SG11202009570S A SG 11202009570SA
- Authority
- SG
- Singapore
- Prior art keywords
- atf6
- inhibitors
- atf6 inhibitors
- Prior art date
Links
- 101150014641 Atf6 gene Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862654263P | 2018-04-06 | 2018-04-06 | |
| PCT/US2019/026198 WO2019195810A2 (en) | 2018-04-06 | 2019-04-06 | Atf6 inhibitors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009570SA true SG11202009570SA (en) | 2020-10-29 |
Family
ID=66248737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009570SA SG11202009570SA (en) | 2018-04-06 | 2019-04-06 | Atf6 inhibitors and uses thereof |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10829485B2 (en) |
| EP (1) | EP3774782A2 (en) |
| JP (1) | JP2021521271A (en) |
| KR (1) | KR20210028144A (en) |
| CN (1) | CN112313224A (en) |
| AU (1) | AU2019247533B2 (en) |
| BR (1) | BR112020020181A2 (en) |
| CA (1) | CA3096139A1 (en) |
| CL (1) | CL2020002573A1 (en) |
| IL (1) | IL277794B2 (en) |
| MX (1) | MX2020010469A (en) |
| RU (1) | RU2020136310A (en) |
| SG (1) | SG11202009570SA (en) |
| WO (1) | WO2019195810A2 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022004212A (en) * | 2019-10-09 | 2022-06-08 | Praxis Biotech LLC | Atf6 modulators and uses thereof. |
| CN115087656A (en) * | 2019-10-09 | 2022-09-20 | 普拉西斯生物技术有限责任公司 | ATF6 modulators and uses thereof |
| EP4001917A1 (en) | 2020-11-12 | 2022-05-25 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Inhibitors for use in treating liver disorders |
| KR102644194B1 (en) * | 2021-02-22 | 2024-03-08 | 주식회사 이노셀젠헬스케어 | ATF6 as a target protein for diagnosis or treatment of tumor |
| WO2022266232A1 (en) * | 2021-06-16 | 2022-12-22 | Sanford Burnham Prebys Medical Discovery Institute | Methods and compositions for treating chronic liver disease and hepatocellular carcinoma |
| CN113501787A (en) * | 2021-08-20 | 2021-10-15 | 黑龙江省科学院石油化学研究院 | Method for synthesizing 6-trifluoromethyl-3-methylindazole |
| WO2024015425A1 (en) | 2022-07-14 | 2024-01-18 | Fmc Corporation | Herbicidal benzoxazines |
| KR20240030727A (en) * | 2022-08-31 | 2024-03-07 | 단국대학교 천안캠퍼스 산학협력단 | Furyl thiazole compound and composition for preventing or treating sarcopenia comprising the same as an active ingredient |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK15532000A3 (en) * | 1998-04-20 | 2001-12-03 | Pfizer Inc. | Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| ATE482200T1 (en) * | 2003-05-01 | 2010-10-15 | Bristol Myers Squibb Co | ARYL-SUBSTITUTED PYRAZOLAMIDE COMPOUNDS SUITABLE AS KINASE INHIBITORS |
| BRPI0620464A2 (en) * | 2005-12-23 | 2011-11-16 | Astrazeneca Ab | compound, pharmaceutical composition, use of a compound, and method for treating a disease |
| AR069650A1 (en) * | 2007-12-14 | 2010-02-10 | Actelion Pharmaceuticals Ltd | DERIVATIVES OF AMINOPIRAZOL AS NON-PEPTIDIC AGONISTS OF THE HUMAN ALX RECEPTOR |
| US8642660B2 (en) * | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| PT2403499T (en) * | 2009-03-02 | 2019-12-19 | Stemsynergy Therapeutics Inc | Methods and compositions for use in treating cancer and reducing wnt mediated effects in a cell |
| JP5721187B2 (en) * | 2009-12-22 | 2015-05-20 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | Isoindolinone inhibitor of phosphatidylinositol 3-kinase |
| EP2882718A4 (en) * | 2012-08-10 | 2015-12-23 | Hoffmann La Roche | Pyrazole carboxamide compounds, compositions and methods of use |
| WO2014055944A1 (en) * | 2012-10-04 | 2014-04-10 | Oyagen, Inc. | Small molecules as anti-hiv agents that disrupt vif self-association and methods of use thereof |
| KR20170138457A (en) * | 2015-04-22 | 2017-12-15 | 리겔 파마슈티칼스, 인크. | Pyrazole compounds and methods of making and using such compounds |
| CN107922386B (en) * | 2015-06-22 | 2021-04-02 | 大日本住友制药株式会社 | 1, 4-disubstituted imidazole derivatives |
| SG10202012498TA (en) * | 2015-12-16 | 2021-01-28 | Loxo Oncology Inc | Compounds useful as kinase inhibitors |
| JP6896701B2 (en) * | 2016-02-26 | 2021-06-30 | 大日本住友製薬株式会社 | Imidazolylamide derivative |
| US10357477B2 (en) * | 2016-09-13 | 2019-07-23 | Regents Of The University Of Minnesota | Anticancer compounds |
-
2019
- 2019-04-06 JP JP2021504139A patent/JP2021521271A/en active Pending
- 2019-04-06 CN CN201980037115.9A patent/CN112313224A/en active Pending
- 2019-04-06 BR BR112020020181-2A patent/BR112020020181A2/en not_active Application Discontinuation
- 2019-04-06 WO PCT/US2019/026198 patent/WO2019195810A2/en active Application Filing
- 2019-04-06 AU AU2019247533A patent/AU2019247533B2/en active Active
- 2019-04-06 KR KR1020207031697A patent/KR20210028144A/en unknown
- 2019-04-06 MX MX2020010469A patent/MX2020010469A/en unknown
- 2019-04-06 EP EP19719005.1A patent/EP3774782A2/en active Pending
- 2019-04-06 IL IL277794A patent/IL277794B2/en unknown
- 2019-04-06 RU RU2020136310A patent/RU2020136310A/en unknown
- 2019-04-06 US US16/377,156 patent/US10829485B2/en active Active
- 2019-04-06 SG SG11202009570SA patent/SG11202009570SA/en unknown
- 2019-04-06 CA CA3096139A patent/CA3096139A1/en active Pending
-
2020
- 2020-08-12 US US16/992,000 patent/US20210221803A1/en not_active Abandoned
- 2020-10-05 CL CL2020002573A patent/CL2020002573A1/en unknown
-
2023
- 2023-05-26 US US18/324,826 patent/US20240124434A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20190367497A1 (en) | 2019-12-05 |
| RU2020136310A3 (en) | 2022-05-06 |
| IL277794A (en) | 2020-11-30 |
| WO2019195810A2 (en) | 2019-10-10 |
| US20240124434A1 (en) | 2024-04-18 |
| US10829485B2 (en) | 2020-11-10 |
| CN112313224A (en) | 2021-02-02 |
| WO2019195810A3 (en) | 2019-11-21 |
| JP2021521271A (en) | 2021-08-26 |
| CL2020002573A1 (en) | 2021-03-05 |
| KR20210028144A (en) | 2021-03-11 |
| MX2020010469A (en) | 2021-04-19 |
| CA3096139A1 (en) | 2019-10-10 |
| IL277794B1 (en) | 2023-10-01 |
| AU2019247533A1 (en) | 2020-10-15 |
| EP3774782A2 (en) | 2021-02-17 |
| AU2019247533B2 (en) | 2023-09-28 |
| RU2020136310A (en) | 2022-05-06 |
| BR112020020181A2 (en) | 2021-01-19 |
| IL277794B2 (en) | 2024-02-01 |
| US20210221803A1 (en) | 2021-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282487A (en) | Tyk2 inhibitors and uses thereof | |
| IL283639A (en) | Kif18a inhibitors | |
| IL271999A (en) | Tyk2 inhibitors and uses thereof | |
| IL277794A (en) | Atf6 inhibitors and uses thereof | |
| GB202107039D0 (en) | PFKFB3 inhibitors and their uses | |
| GB201605126D0 (en) | Inhibitors and their uses | |
| IL282090A (en) | Tyk2 inhibitors and uses thereof | |
| IL270330B (en) | Beta-lactamase inhibitors and uses thereof | |
| IL283409A (en) | Tyk2 inhibitors and uses thereof | |
| HUE063120T2 (en) | Lrrc33 inhibitors and use thereof | |
| IL282350A (en) | Rgmc-selective inhibitors and use thereof | |
| PT3712147T (en) | Sglts inhibitor and application thereof | |
| IL276013A (en) | Pi4kiiibeta inhibitors | |
| IL292198A (en) | Tim-3 inhibitors and uses thereof | |
| IL281357B (en) | Cd73 inhibitors and pharmaceutical uses thereof | |
| IL277502A (en) | Compounds and uses thereof | |
| IL274523A (en) | Immunoproteasome inhibitors | |
| PT3571208T (en) | Immunoproteasome inhibitors | |
| IL281514A (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors | |
| LT3710457T (en) | Immunoproteasome inhibitors | |
| IL283106A (en) | Erk inhibitors and uses thereof | |
| IL280408A (en) | Cdk inhibitors and uses thereof | |
| GB201812462D0 (en) | Inhibitors | |
| GB201804439D0 (en) | Dopamin-b-hydroxylase inhibitors |